IL35545A - Streptokinase chemically bonded to a water soluble dextran support medium - Google Patents

Streptokinase chemically bonded to a water soluble dextran support medium

Info

Publication number
IL35545A
IL35545A IL35545A IL3554570A IL35545A IL 35545 A IL35545 A IL 35545A IL 35545 A IL35545 A IL 35545A IL 3554570 A IL3554570 A IL 3554570A IL 35545 A IL35545 A IL 35545A
Authority
IL
Israel
Prior art keywords
streptokinase
dextran
weight
composition
support medium
Prior art date
Application number
IL35545A
Other languages
English (en)
Other versions
IL35545A0 (en
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of IL35545A0 publication Critical patent/IL35545A0/xx
Publication of IL35545A publication Critical patent/IL35545A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166Streptokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
IL35545A 1969-12-02 1970-10-27 Streptokinase chemically bonded to a water soluble dextran support medium IL35545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88163269A 1969-12-02 1969-12-02

Publications (2)

Publication Number Publication Date
IL35545A0 IL35545A0 (en) 1970-12-24
IL35545A true IL35545A (en) 1974-06-30

Family

ID=25378866

Family Applications (1)

Application Number Title Priority Date Filing Date
IL35545A IL35545A (en) 1969-12-02 1970-10-27 Streptokinase chemically bonded to a water soluble dextran support medium

Country Status (11)

Country Link
US (1) US3639213A (de)
BE (1) BE758425A (de)
CA (1) CA976101A (de)
DE (1) DE2059165A1 (de)
DK (1) DK131471B (de)
FR (1) FR2073443B1 (de)
GB (1) GB1325912A (de)
IL (1) IL35545A (de)
IT (1) IT1050704B (de)
NL (1) NL7017625A (de)
ZA (1) ZA707355B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167446A (en) * 1973-03-15 1979-09-11 Bayer Aktiengesellschaft Water soluble carrier-bound penicillinacylase
US3865615A (en) * 1973-05-07 1975-02-11 Air Prod & Chem Non-thrombogenic plastics
GB1479268A (en) * 1973-07-05 1977-07-13 Beecham Group Ltd Pharmaceutical compositions
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4273873A (en) * 1977-10-25 1981-06-16 Unitika Ltd. Preparation of antithrombogenic polymeric materials
US4305926A (en) * 1979-09-13 1981-12-15 Johannes Everse Immobilization of Streptokinase
DE3033029A1 (de) * 1979-09-28 1981-04-23 Vsesojuznyj kardiologičeskij naučnyj centr Akademii medicinskich Nauk SSSR,, Moskva Urokinasederivate und verfahren zu deren herstellung
IT1209419B (it) * 1980-07-01 1989-07-16 Texcontor Ets Composti ad attivita' mucolitica non assimilabili, processo per laloro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
JPH04503607A (ja) * 1989-02-24 1992-07-02 イムノセラピューティックス・インコーポレイテッド 固定化サイトカイン類
US5230891A (en) * 1990-08-20 1993-07-27 Kanebo Limited Modified protease, method of producing the same and cosmetic products containing the modified protease
US5133968A (en) * 1990-08-20 1992-07-28 Kanebo, Ltd. Modified protease, method of producing the same and cosmetic products containing the modified protease
US5595732A (en) * 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
WO1993020838A1 (en) * 1992-04-20 1993-10-28 Rufeld, Inc. Method and compositions for treatment of pyonecrotic processes
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
KR20160110544A (ko) * 2008-06-04 2016-09-21 그리폴스 테라퓨틱스 인코포레이티드 플라스민의 제조를 위한 조성물, 방법 및 키트
US9206410B2 (en) 2009-03-03 2015-12-08 Grifols Therapeutics Inc. Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom
US9791463B2 (en) 2013-03-15 2017-10-17 Lawrence Livermore National Security, Llc Methods for the selective detection of alkyne-presenting molecules and related compositions and systems
CN104758945B (zh) * 2015-02-26 2018-10-16 宁波大学 一种pH响应的溶栓药物靶向纳米凝胶及其合成方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL287978A (de) * 1962-10-17 1900-01-01
US3255094A (en) * 1963-01-10 1966-06-07 Baxter Laboratories Inc Method for purification of streptokinase
DE1517761A1 (de) * 1965-03-20 1970-01-29 Kyowa Hakko Kogyo Kk Wasserunloesliche Enzyme
US3824150A (en) * 1967-07-14 1974-07-16 Nat Res Dev Enzyme bound to polymeric sheet with a triazine bridging group

Also Published As

Publication number Publication date
BE758425A (fr) 1971-04-16
CA976101A (en) 1975-10-14
GB1325912A (en) 1973-08-08
DK131471B (da) 1975-07-21
ZA707355B (en) 1971-07-28
DE2059165A1 (de) 1971-06-09
IL35545A0 (en) 1970-12-24
FR2073443A1 (de) 1971-10-01
US3639213A (en) 1972-02-01
FR2073443B1 (de) 1975-04-18
DK131471C (de) 1975-12-08
IT1050704B (it) 1981-03-20
NL7017625A (de) 1971-06-04

Similar Documents

Publication Publication Date Title
US3980772A (en) Methods of dissolving blood clots and the like with streptokinase chemically bonded to a carbohydrate matrix
IL35545A (en) Streptokinase chemically bonded to a water soluble dextran support medium
US4954622A (en) Pharmaceutical composition and method containing gamma inulin or derivative thereof
EP0073371B1 (de) Intravenös injektierbares Globulin aus Immunserum und Verfahren zu seiner Herstellung
US4401592A (en) Pharmaceutical composition having antitumor activity
US4681870A (en) Protein A-silica immunoadsorbent and process for its production
US4499073A (en) Intravenously injectable immune serum globulin
RU2236257C1 (ru) Синтетический иммуноген для терапии и профилактики злоупотреблений наркотическими и психоактивными веществами
EP0719551A2 (de) Isolierung von Aminoarginin und Verwendung zur Blockierung der Bildung von Stickstoffoxyden im Körper
JPH03503887A (ja) 自己免疫疾患に対する抗t細胞イムノトキシンの治療的使用
PL99599B1 (pl) Sposob otrzymywania tolerowanej srodzylnie gammaglobuliny
JPH02108624A (ja) 抗hiv作用を有するヘパリンフラグメント及びフラクション
JPS6322801A (ja) Edta不含のヘパリン、ヘパリン分画ならびに断片、それらの製造法及びそれらを含有する医薬品組成物
JPH0579649B2 (de)
US2446974A (en) Synthesis of a penicillin-protein reaction product
CA2195863C (en) Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby
JPH0572903B2 (de)
JP3769045B2 (ja) 抗炎症剤
CZ289560B6 (cs) Způsob výroby přípravku obsahujícího hyaluronidázu
KR20020031404A (ko) 혈장 대체 조성물
AU589233B2 (en) Immunotherapeutic treatment
Seal Isolation of an active polysaccharide fraction from plague organisms.
JPS59167515A (ja) 免疫機能増強剤
RU2032660C1 (ru) Способ получения комплексов на основе ациклических аминов, обладающих радиопротекторными свойствами
CA2180732A1 (en) Anti-hiv drugs